What Fluoroquinolones Have the Highest Risk of Aortic Aneurysm? A Case/Non-case Study in VigiBase®

Overview

Journal J Gen Intern Med

Publisher Springer

Specialty General Medicine

Date 2018 Dec 20

PMID 30565153

Citations 7

Authors

Agnes Sommet

Justine Benevent

Vanessa Rousseau

Leila Chebane

Antonios Douros

Jean-Louis Montastruc

Francois Montastruc

Affiliations

Soon will be listed here.

Citing Articles

Biotransformation of the Fluoroquinolone Antibiotic, Levofloxacin, by the Free and Immobilized Secretome of .

Staita K, Khmaissa M, Akrout I, Greff S, Ghariani B, Turbe-Doan A J Fungi (Basel). 2024; 10(12).

PMID: 39728357 PMC: 11677856. DOI: 10.3390/jof10120861.

Effect of FluoRoquinolones on Aortic Growth, aortic stIffness and wave refLEctionS (FRAGILES study).

Gardikioti V, Georgakopoulos C, Solomou E, Lazarou E, Fasoulakis K, Terentes-Printzios D Life (Basel). 2024; 14(8).

PMID: 39202735 PMC: 11355559. DOI: 10.3390/life14080992.

Impact of the US Food and Drug Administration warning regarding increased risk of aortic aneurysms or aortic dissections on fluoroquinolone prescribing trends.

Rizk J, Slejko J, Heil E, Seo D, Qato D BMJ Open Qual. 2024; 13(3.

PMID: 39053916 PMC: 11733791. DOI: 10.1136/bmjoq-2024-002925.

Pharmacovigilance Strategies to Address Resistance to Antibiotics and Inappropriate Use-A Narrative Review.

Sandes V, Figueras A, Lima E Antibiotics (Basel). 2024; 13(5).

PMID: 38786184 PMC: 11117530. DOI: 10.3390/antibiotics13050457.

The Research Status, Potential Hazards and Toxicological Mechanisms of Fluoroquinolone Antibiotics in the Environment.

Du J, Liu Q, Pan Y, Xu S, Li H, Tang J Antibiotics (Basel). 2023; 12(6).

PMID: 37370377 PMC: 10295583. DOI: 10.3390/antibiotics12061058.

References

Montastruc J, Sommet A, Bagheri H, Lapeyre-Mestre M . Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database. Br J Clin Pharmacol. 2011; 72(6):905-8. PMC: 3244636. DOI: 10.1111/j.1365-2125.2011.04037.x. View

Pasternak B, Inghammar M, Svanstrom H . Fluoroquinolone use and risk of aortic aneurysm and dissection: nationwide cohort study. BMJ. 2018; 360:k678. PMC: 5842359. DOI: 10.1136/bmj.k678. View

Pierfitte C, Begaud B, Lagnaoui R, Moore N . Is reporting rate a good predictor of risks associated with drugs?. Br J Clin Pharmacol. 1999; 47(3):329-31. PMC: 2014220. DOI: 10.1046/j.1365-2125.1999.00881.x. View

Daneman N, Lu H, Redelmeier D . Fluoroquinolones and collagen associated severe adverse events: a longitudinal cohort study. BMJ Open. 2015; 5(11):e010077. PMC: 4654346. DOI: 10.1136/bmjopen-2015-010077. View

Lee C, Lee M, Chen Y, Lee S, Chen Y, Chen S . Risk of Aortic Dissection and Aortic Aneurysm in Patients Taking Oral Fluoroquinolone. JAMA Intern Med. 2015; 175(11):1839-47. DOI: 10.1001/jamainternmed.2015.5389. View